Welcome to LookChem.com Sign In|Join Free
  • or
3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one, also known as 2H-1-benzopyran-2-one, is a heterocyclic chemical compound characterized by the presence of a benzimidazole ring and a benzopyran backbone. It is widely recognized in medicinal chemistry and drug design for its diverse biological activities, such as antitumor, antiviral, and antibacterial properties, along with potential applications as an anti-inflammatory and antioxidant agent. The unique structure and properties of 3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one position it as a promising candidate for pharmaceutical research and development.

1032-97-9

Post Buying Request

1032-97-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1032-97-9 Usage

Uses

Used in Pharmaceutical Industry:
3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one is used as a pharmaceutical agent for its demonstrated antitumor activity, making it a candidate for the development of new cancer treatments. Its antiviral and antibacterial properties also suggest potential applications in the treatment of viral and bacterial infections.
Used in Anti-inflammatory Applications:
3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one is utilized as an anti-inflammatory agent due to its potential to modulate inflammatory responses, which could be beneficial in the management of various inflammatory conditions.
Used in Antioxidant Formulations:
As an antioxidant agent, 3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one is employed to protect cells from oxidative damage, which is crucial in the prevention and treatment of a range of diseases associated with oxidative stress.
Used in Drug Design and Medicinal Chemistry Research:
3-(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-one serves as a key compound in drug design and medicinal chemistry research, where its structure and properties are studied and optimized for the development of novel therapeutic agents with improved efficacy and safety profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 1032-97-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,3 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1032-97:
(6*1)+(5*0)+(4*3)+(3*2)+(2*9)+(1*7)=49
49 % 10 = 9
So 1032-97-9 is a valid CAS Registry Number.

1032-97-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1H-benzimidazol-2-yl)chromen-2-one

1.2 Other means of identification

Product number -
Other names 3-benzimidazole cumarin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1032-97-9 SDS

1032-97-9Downstream Products

1032-97-9Relevant academic research and scientific papers

Synthesis and antidepressant activity of some new coumarin derivatives

Abdel-Latif, Nehad A.

, p. 195 - 216 (2007/10/03)

The coumarin-3-cinnamoyl derivatives 2a-d were prepared via Claisen-Schmidt condensation of 3-acetylcoumarin 1 with different aromatic aldehydes. Cycloaddition reaction of 2b,e with guanidine and thiourea yielded the corresponding aminopyrmimidine 3a,b and thioxypyrimidine derivatives 4a,b, respectively. Compounds 4a,b were condensed with chloroacetic acid or 3-bromopropionic acid to yield coumarin 3-thiazolo-pyrimidine 5a,b and thiazinopyrimidine 6a,b derivatives, respectively. Compounds 4a,b were condensed with chloroacetic acid and aromatic aldehyde to yield the aryl methylene derivatives 7a,b which could be prepared directly by condensation of compounds 5a,b with aromatic aldehydes. Compounds 2a-e were condensed with malononitrile or ethyl cyano acetate in presence of ammonium acetate to yield cyanopyridine 8a,b and cyanopyridone 9a-d derivatives, respectively, which were prepared by condensation of 3-acetylcoumarin 1, malononitrile or ethylcyanoacetate and aromatic aldehydes in presence of ammonium acetate. Condensation of compounds 2a,b,e with o-phenylenediamine in refluxing ethanol led to the formation of 10a-c as intermediate, followed by cleavage by thermolysis to benzimidazole derivative 11 along with compounds 12a-c as mixture, which were obtained directly by fusion of α,β,-unsaturated ketones 2 with o-phenylene diamine at 200-220°C, while compound 11 could be prepared in pure form by fusion of 1 with o-phenylene diamine at the same temperature. The pharmacological screening showed that many of these obtained compounds have good antidepressant activity comparable to Tranylcypromine as reference drugs. O?sterreichische Apotheker-Verlagsgesellschaft m. b. H.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1032-97-9